Xiaobin Tang

Xiaobin Tang is a Principal Scientist in Translational Medicine Oncology at Genentech, a position held since 2022. Prior experience includes roles as a Senior Scientist in Clinical Biomarker and Translational Science at Lyell Immunopharma (2021-2022), and as an IND Quality Control Supervisor at Stanford Health Care (2020-2021). Previous positions also include Senior Associate Scientist in Inflammation & Oncology at Amgen (2017-2020), Senior Scientist in Cell Biology at Atreca, Inc. (2016-2017), Academic Staff Researcher at Stanford University School of Medicine (2009-2015), and Visiting Research Fellow at the National Institute of Allergy and Infectious Diseases (NIAID) (2004-2009). Xiaobin Tang earned a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from Peking Union Medical College.